EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of insurance type on outpatient mental health treatment of US adults

Lydia A Chwastiak iD, Scott Graupensperger iD, Heather Ringeisen iD, Mark Edlund, Heidi Guyer, Natalie Bareis iD, Maria Monroe-Devita, Lisa Dixon, Scott Stroup, Jeffrey Swanson, Marvin Swartz iD, Elizabeth Sinclair Hancq iD und 3 weitere

PLOS Mental Health · 09.05.2025 · 2 (5) · e0000299

DOI: 10.1371/journal.pmen.0000299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Mental Health, online erschienen am 09.05.2025. Verfasst von Lydia A Chwastiak und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, United States of America. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, Center for Mental Health Services.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mental health treatment gap in the US continues to be a major public health challenge. Even individuals with health insurance face substantial barriers to care, including high costs, insufficient coverage and inaccurate provider directories. Policies to address the treatment gap require updated population-based information about whether treatment rates vary by type of insurance. The current study aimed to compare past-year outpatient mental health treatment across insurance types (private, Medicare, Medicaid, other, or none), in the household sample of non-elderly adults in the Mental and Substance Use Disorder Prevalence Study (MDPS), (n = 4,640). MDPS, fielded October 2020 through October 2022, identified 12-month prevalence of mental disorders and rates of treatment among US adults from interviews by trained clinicians using the Structured Clinical Interview for DSM-5. Logistic regressions estimated odds of treatment among participants with a past-year MDPS diagnosis across insurance types, after adjusting for age, sex, race/ethnicity, income level, diagnosis, and functional impairment. Analyses were weighted to reflect the US adult population. 60.2% of the 1,833 participants with an MDPS mental disorder received outpatient treatment in the past year. Compared to participants with private insurance, those with no insurance had lower odds of outpatient treatment (AOR = 0.37 [0.16-0.87]). Participants with Medicare had higher odds of treatment (AOR = 4.25 [1.56-11.64]), suggesting that individuals with complex and disabling illness were least likely to have treatment disruptions during the early phases of the pandemic. Differences between groups decreased as the pandemic progressed, but utilization of services only significantly increased among individuals with private insurance. Persisting mental health treatment gaps in the US vary by type of health insurance, which warrants extensive policy reforms.

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, United States of America.
  • RTI International, Research Triangle Park, North Carolina, United States of America.
  • Department of Psychiatry, Columbia University School of Medicine, New York State Psychiatric Institute, New York, New York, United States of America.
  • Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Treatment Advocacy Center, Arlington, Virginia, United States of America.
  • Department of Public Health Sciences, University of Chicago, Chicago, Illinois, United States of America.

ORCID-Profile: Lydia A Chwastiak, Scott Graupensperger, Heather Ringeisen, Natalie Bareis, Marvin Swartz, Elizabeth Sinclair Hancq, Mark Olfson

Förderung

  • NIMH NIH HHS
  • Center for Mental Health Services

Zitieren

APA

Chwastiak, L. A., Graupensperger, S., Ringeisen, H., Edlund, M., Guyer, H., Bareis, N., Monroe-Devita, M., Dixon, L., Stroup, S., Swanson, J., Swartz, M., Hancq, E. S., Gibbons, R., Kessler, R. C., & Olfson, M. (2025). Impact of insurance type on outpatient mental health treatment of US adults. PLOS Mental Health, 2(5), e0000299. https://doi.org/10.1371/journal.pmen.0000299

Vancouver

Chwastiak LA, Graupensperger S, Ringeisen H, Edlund M, Guyer H, Bareis N, et al. Impact of insurance type on outpatient mental health treatment of US adults. PLOS Mental Health. 2025;2(5):e0000299. doi:10.1371/journal.pmen.0000299

BibTeX
@article{Chwastiak2025,
  author = {Chwastiak, Lydia A and Graupensperger, Scott and Ringeisen, Heather and Edlund, Mark and Guyer, Heidi and Bareis, Natalie and Monroe-Devita, Maria and Dixon, Lisa and Stroup, Scott and Swanson, Jeffrey and Swartz, Marvin and Hancq, Elizabeth Sinclair and Gibbons, Robert and Kessler, Ronald C and Olfson, Mark},
  title = {Impact of insurance type on outpatient mental health treatment of US adults},
  journal = {PLOS Mental Health},
  year = {2025},
  volume = {2},
  number = {5},
  pages = {e0000299},
  doi = {10.1371/journal.pmen.0000299}
}
Kostenlos starten →